编者按：2025年以来，siRNA疗法在治疗凝血相关疾病的研究方面取得了重要里程碑进展。RNA干扰（RNAi）机制通过在肝脏细胞中沉默编码凝血因子或天然抗凝物的mRNA，为治疗凝血相关疾病提供了一种全新的治疗模式。基于GalNAc偶联的递送技术，是将 ...

Superwarfarins represent a class of long‐acting anticoagulant rodenticides that exert their effect through profound inhibition of vitamin K recycling, primarily by targeting vitamin K epoxide ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five ...

Research by RCSI University of Medicine and Health Sciences has discovered a new role for the blood clotting protein, von Willebrand Factor (VWF), that could lead to the development of new treatments ...

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The global heparin market size is estimated to grow by USD 3.34 billion from 2024-2028, according to ...

To help diagnose von Willebrand disease or other bleeding disorders, a doctor will request various blood tests. These tests will measure the presence and activity of certain substances in the blood.

The 500 million international units (IUs) will include product specifically manufactured for donation allowing for a longer shelf life and enabling more people around the world to access life-saving ...

Add Yahoo as a preferred source to see more of our stories on Google. Blood clot made of red blood cells, platelets and fibrin protein strands. Thrombus, 3D illustration (Getty Images/iStockphoto) A ...

The Centers for Disease Control and Prevention is accepting grant applications for research on using hemostasis and thrombosis centers to prevent or reduce complications related to bleeding and ...